Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003413017 | SCV004138015 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | COX4I1: BP4 |
Ambry Genetics | RCV004907845 | SCV005566944 | uncertain significance | not specified | 2024-11-08 | criteria provided, single submitter | clinical testing | The c.122G>A (p.R41Q) alteration is located in exon 3 (coding exon 2) of the COX4I1 gene. This alteration results from a G to A substitution at nucleotide position 122, causing the arginine (R) at amino acid position 41 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |